Journal of Medicinal Chemistry p. 9382 - 9394 (2015)
Update date:2022-07-30
Topics:
Papillon, Julien P. N.
Lou, Changgang
Singh, Alok K.
Adams, Christopher M.
Ksander, Gary M.
Beil, Michael E.
Chen, Wei
Leung-Chu, Jennifer
Fu, Fumin
Gan, Lu
Hu, Chii-Whei
Jeng, Arco Y.
Lasala, Daniel
Liang, Guiqing
Rigel, Dean F.
Russell, Kerry S.
Vest, John A.
Watson, Catherine
Human clinical studies conducted with LCI699 established aldosterone synthase (CYP11B2) inhibition as a promising novel mechanism to lower arterial blood pressure. However, LCI699's low CYP11B1/CYP11B2 selectivity resulted in blunting of adrenocorticotropic hormone-stimulated cortisol secretion. This property of LCI699 prompted its development in Cushing's disease, but limited more extensive clinical studies in hypertensive populations, and provided an impetus for the search for cortisol-sparing CYP11B2 inhibitors. This paper summarizes the discovery, pharmacokinetics, and pharmacodynamic data in preclinical species and human subjects of the selective CYP11B2 inhibitor 8.
View MoreShenzhen Feiming Science and Technology Co,. Ltd
Contact:+86-755-85232577
Address:#B2309, Fenglin International Center ,Jixiang Road, Longcheng street, LongGang District, Shenzhen city, Guangdong province, China.
Shandong Xiangde Biotechnology Co., Ltd
Contact:+86 -15066639877
Address:Sanba street
Hangzhou Neway Chemicals Co., Ltd.
Contact:+86-571-85095566
Address:Room 803, Qinglian Bldg, No 139 Qingchun Road, Hangzhou, Zhejiang China
QINGDAO ON-BILLION INDUSTRAIL CO.,LTD
website:http://www.obn.com.cn
Contact:+86-15005320811 +86-532-80681989
Address:F35 Parkson Mansion No.44-60 Zhongshan Rd.
Zhejiang Kangfeng Chemical Co.,LTD.
Contact:+86-579-86709687
Address:Xueshizhai Industrial Zone, Weishan Town,Dongyang City, Zhejiang Province ,China
Doi:10.1016/S0040-4020(01)86048-8
(1988)Doi:10.1016/0031-9422(90)80171-C
(1990)Doi:10.3390/molecules170910446
(2012)Doi:10.1021/ja01333a038
(1933)Doi:10.1021/jo00271a050
(1989)Doi:10.1016/j.bmc.2009.10.019
(2009)